SHA:603392 Market Cap

SHA:603392 has a market cap or net worth of 49.70 billion as of March 9, 2026. Its market cap has decreased by -42.11% in one year.

Market Cap

49.70B

Enterprise Value

45.13B

Revenue

1.80B

Ranking

n/a

PE Ratio

n/a

Stock Price

39.31

Market Cap Chart

Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 49.70B, an increase of 809.76%. That is a compound annual growth rate of 45.81%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	49.56B	-12.77%
Dec 31, 2025	56.82B	-36.26%
Dec 31, 2024	89.14B	-6.44%
Dec 29, 2023	95.28B	-17.00%
Dec 30, 2022	114.80B	-14.62%
Dec 31, 2021	134.46B	53.87%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haisco Pharmaceutical Group	52.21B
Pharmaron Beijing	46.31B
Shanghai Allist Pharmaceuticals	43.80B
Shanghai RAAS Blood Products	41.21B
Hebei Changshan Biochemical Pharmaceutical	39.43B
Chongqing Zhifei Biological Products	38.68B
Sunshine Guojian Pharmaceutical (Shanghai)	35.97B
Asymchem Laboratories (Tianjin)	35.00B

Market Cap Rankings